Evidence map›Paper›PMID 31599954›Full record

ArticleThe Journal of infectious diseases2020

Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development.

Karuna P Karunakaran, Hong Yu, Xiaozhou Jiang, Queenie W T Chan, Leonard J Foster, Raymond M Johnson, Robert C Brunham

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. CD8iScience · 2026
    Article
  2. Article
  3. Advances inMicroorganisms · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Karuna P KarunakaranVaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Hong YuVaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Xiaozhou JiangVaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Queenie W T ChanDepartment of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Leonard J FosterDepartment of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.
Raymond M JohnsonSection of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
Robert C BrunhamVaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
BC Centre for Disease Control · CAUniversity of British Columbia · CACanada's Michael Smith Genome Sciences Centre · CAYale University · US

Funding

Role of Plac8 in natural and vaccine-generated immunity against Chlamydia infectionsR01AI113103 · NIAID · YALE UNIVERSITY · PI BRUNHAM, ROBERT CONRAD, JOHNSON, RAYMOND MORRIS · 2014 to 2018
$1.9M
NIAID NIH HHS R01 AI113103
6 · The paper itself

Abstract

backgroundChlamydia trachomatis and Chlamydia muridarum are intracellular bacterial pathogens of mucosal epithelial cells. CD4 T cells and major histocompatibility complex (MHC) class II molecules are essential for protective immunity against them. Antigens presented by dendritic cells (DCs) expand naive pathogen-specific T cells (inductive phase), whereas antigens presented by epithelial cells identify infected epithelial cells as targets during the effector phase. We previously showed that DCs infected by C trachomatis or C muridarum present epitopes from a limited spectrum of chlamydial proteins recognized by Chlamydia-specific CD4 T cells from immune mice.

methodsWe hypothesized that Chlamydia-infected DCs and epithelial cells present overlapping sets of Chlamydia-MHC class II epitopes to link inductive and effector phases to generate protective immunity. We tested that hypothesis by infecting an oviductal epithelial cell line with C muridarum, followed by immunoaffinity isolation and sequencing of MHC class I- and II-bound peptides.

resultsWe identified 26 class I-bound and 4 class II-bound Chlamydia-derived peptides from infected epithelial cells. We were surprised to find that none of the epithelial cell class I- and class II-bound chlamydial peptides overlapped with peptides presented by DCs.

conclusionsWe suggest the discordance between the DC and epithelial cell immunoproteomes has implications for delayed clearance of Chlamydia and design of a Chlamydia vaccine.

Indexed as

AnimalsAntigens, BacterialBacterial VaccinesCD4-Positive T-LymphocytesCell LineChlamydia InfectionsChlamydia muridarumChlamydia trachomatisDendritic CellsEpithelial CellsEpitopes, T-LymphocyteFemaleHeLa CellsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHost-Pathogen InteractionsAntigens, BacterialBacterial VaccinesEpitopes, T-LymphocyteHistocompatibility Antigens Class IHistocompatibility Antigens Class IIPeptidesBm1.11ChlamydiaMHC class IIT cellvaccine

Identifiers

PMID31599954
PMCPMC7457330
OpenAlexW2979914430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.